Literature DB >> 11213276

Aging-related growth hormone (GH) decrease is a selective hypothalamic GH-releasing hormone pulse amplitude mediated phenomenon.

M Russell-Aulet1, E V Dimaraki, C A Jaffe, R DeMott-Friberg, A L Barkan.   

Abstract

BACKGROUND: Aging is accompanied by declining growth hormone (GH) and insulin-like growth factor-I (IGF-I) levels. The neuroendocrine mechanisms of this decline have been studied previously, but the interpretation of the data was confounded by the imprecision in GH measurements and by the intervening variables of altered body composition and decreased gonadal steroid milieu in the elderly subjects of both sexes.
METHODS: To study the contribution of aging per se, we evaluated discrete parameters of GH pulsatility in young (n = 8 women, n = 8 men) and elderly (n = 11 women, in 10 men) subjects closely matched for body mass index. Blood samples for GH were obtained every 10 minutes for 24 hours. Plasma GH was measured by a sensitive chemiluminescent assay. GH pulsatility was assessed using cluster analysis.
RESULTS: The elderly subjects had plasma IGF-I levels and integrated GH concentrations that were 32% to -56% of their sex-matched younger counterparts. The age-associated attenuation in GH was due to a decrease in GH pulse amplitude, whereas pulse frequency and nadir levels were unchanged. The majority of the young subjects (81%) reached their peak GH during the "lights off" period, whereas the majority of the elderly subjects (62%) peaked during the "lights on" period (p = .01).
CONCLUSIONS: We conclude that aging in both sexes is accompanied by profound decreases in GH output and in plasma IGF-I concentrations. This effect is separate from the alterations in body mass index that accompany the normal aging process. Attenuation of GH output associated with aging is related solely to the lower GH and, by inference, GH-releasing hormone (GHRH) pulse amplitude.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11213276     DOI: 10.1093/gerona/56.2.m124

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN: 1079-5006            Impact factor:   6.053


  9 in total

Review 1.  [Dermatoendocrinology. Skin aging].

Authors:  E Makrantonaki; C C Zouboulis
Journal:  Hautarzt       Date:  2010-06       Impact factor: 0.751

2.  Tyrosine Hydroxylase Neurons Regulate Growth Hormone Secretion via Short-Loop Negative Feedback.

Authors:  Frederick Wasinski; João A B Pedroso; Willian O Dos Santos; Isadora C Furigo; David Garcia-Galiano; Carol F Elias; Edward O List; John J Kopchick; Raphael E Szawka; Jose Donato
Journal:  J Neurosci       Date:  2020-04-21       Impact factor: 6.167

3.  Can a glucagon stimulation test characterized by lower GH cut-off value be used for the diagnosis of growth hormone deficiency in adults?

Authors:  Halit Diri; Zuleyha Karaca; Yasin Simsek; Fatih Tanriverdi; Kursad Unluhizarci; Ahmet Selcuklu; Fahrettin Kelestimur
Journal:  Pituitary       Date:  2015-12       Impact factor: 4.107

4.  The pattern of growth hormone delivery to peripheral tissues determines insulin-like growth factor-1 and lipolytic responses in obese subjects.

Authors:  Sowmya Surya; Jeffrey F Horowitz; Naila Goldenberg; Alla Sakharova; Matthew Harber; Andrea S Cornford; Kathy Symons; Ariel L Barkan
Journal:  J Clin Endocrinol Metab       Date:  2009-05-26       Impact factor: 5.958

Review 5.  Crosstalk between the circadian clock circuitry and the immune system.

Authors:  Nicolas Cermakian; Tanja Lange; Diego Golombek; Dipak Sarkar; Atsuhito Nakao; Shigenobu Shibata; Gianluigi Mazzoccoli
Journal:  Chronobiol Int       Date:  2013-05-22       Impact factor: 2.877

6.  Complex rhythmicity and age dependence of growth hormone secretion are preserved in patients with acromegaly: further evidence for a present hypothalamic control of pituitary somatotropinomas.

Authors:  Antônio Ribeiro-Oliveira; Marcelo Militão Abrantes; Ariel L Barkan
Journal:  J Clin Endocrinol Metab       Date:  2013-05-02       Impact factor: 5.958

Review 7.  Evidence for the Contribution of Gut Microbiota to Age-Related Anabolic Resistance.

Authors:  Matthew D Watson; Brett L Cross; Gregory J Grosicki
Journal:  Nutrients       Date:  2021-02-23       Impact factor: 5.717

8.  Sermorelin: a better approach to management of adult-onset growth hormone insufficiency?

Authors:  Richard F Walker
Journal:  Clin Interv Aging       Date:  2006       Impact factor: 4.458

9.  An open-label clinical trial of the effects of age and gender on the pharmacodynamics, pharmacokinetics and safety of the ghrelin receptor agonist anamorelin.

Authors:  Philip T Leese; John M Trang; Robert A Blum; Eleanor de Groot
Journal:  Clin Pharmacol Drug Dev       Date:  2015-02-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.